Cognixion Recognized by TIME for Best Inventions of 2025
Cognixion's non-invasive brain-computer interface powered by conversational AI, has been honored by TIME Magazine as one of the Best Inventions...
Clinical Trial
Konan Medical’s objective FIELD(R) Perimeter Obtains CE Mark Under MDR
objectiveFIELD is the first and only truly objective perimeter FDA 510(k) cleared to assess visual field abnormalitiesIrvine, California--(Newsfile Corp. -...
Ensysce Biosciences Releases Symposium Highlights from PAINWeek 2025
~ Pain Management, RE-Invented: Ushering in a New Era for Analgesia ~ SAN DIEGO, CA / ACCESS Newswire / October...
YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities
Taipei, Taiwan, Oct. 10, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology...
CRISPR Therapeutics Presents New Preclinical Data for CTX460™ Demonstrating In Vivo Gene Correction of Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase™ Editing Platform
-Preclinical data presented at the European Society of Gene and Cell Therapy (ESGCT) highlight a potential best-in-class profile- -The AATD...
AskBio Presents Interim Safety Results from Phase 1/Phase 2 LION-CS101 Clinical Trial of AB-1003 in Participants with Limb-Girdle Muscular Dystrophy 2I/R9
Research Triangle Park, N.C., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Data from first cohort of five participants suggest an acceptable...
Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’
Presentation title: “Advancing Alzheimer’s Disease Care: Convenience for Both Patients and Families with Oral Blarcamesine” NEW YORK, Oct. 10, 2025...
Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
– An analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed continuing improvements in...
Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Announced clinical development plans for bexobrutideg, including the initiation of pivotal trials in relapsed/refractory CLL in H2 2025 Presented preclinical...
Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
– Complete B cell depletion, rapid reduction in autoantibodies and near-complete resolution of clinical symptoms in two of three refractory...
Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data at the American Academy of Ophthalmology (AAO) 2025 Annual Meeting, October 18-21 in Orlando
Results from the study of oral gildeuretinol in moderate Stargardt disease to be presented as late-breaker during Retina Subspecialty DayCAMBRIDGE,...
Genflow Biosciences PLC Announces Update on Animal Health Program
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET...
THERABODY’S THERAFACE DEPUFFING WAND AND THERMBACK LED RECOGNIZED ON TIME’S BEST INVENTIONS OF 2025
Dual Recognition Underscores Therabody's Leadership in Driving the Future of Wellness with Science-Backed, Clinically Proven Innovations LOS ANGELES, Oct. 9,...
Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer’s Disease Research
New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development. FREMONT, Calif., Oct. 9,...
Doceree expands Spark integration to Oracle Health, deepening AI-driven HCP engagement across leading EHR systems
SHORT HILLS, N.J., Oct. 9, 2025 /PRNewswire/ -- Doceree, the only AI-powered Operating System for healthcare marketing, today announced the integration...
OUTCOMES4ME NAMED TO TIME’S LIST OF THE BEST INVENTIONS OF 2025
BOSTON, Oct. 9, 2025 /PRNewswire/ -- Today, Outcomes4Me announced it has been named to TIME's Best Inventions of 2025 list....
Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions
TIME Best Inventions honors extraordinary innovations changing lives DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader...
FYR Integrates CIQ Fuzzball to Scale AI-Enabled Multiomic Platform and Accelerate Breakthroughs in Precision Medicine
Fuzzball enables FYR's EV-Omics platform to process complex data at production scale to create reproducible, high-quality analytical pipelines in hours,...
New AI solution offers real-time peek into the mind of clinical trial participants
Cognivia Signal expected to reduce trial dropout risk and placebo impact for pharma and biotech trial sponsors. MONT-SAINT-GUIBERT, Belgium, Oct....
Lindus Health Expands All-in-One CRO Capabilities with Enhanced In-House Patient Recruitment Capabilities
BOSTON, Oct. 9, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science...